Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Harshman LC"'
Autor:
Galsky MD, Pal SK, Chowdhury S, Harshman LC, Crabb SJ, Wong YN, Yu EY, Powles T, Moshier EL, Ladoire S, Hussain SA, Agarwal N, Vaishampayan UN, Recine F, Berthold D, Necchi A, Theodore C, Milowsky MI, Bellmunt J, Rosenberg JE
BACKGROUNDGemcitabine plus cisplatin (GC) has been adopted as a neoadjuvant regimen for muscle-invasive bladder cancer despite the lack of Level I evidence in this setting. METHODSData were collected using an electronic data-capture platform from 28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::842aa2c019e931bade68666cf67832b3
Autor:
Chang SL, Harshman LC, Presti JC Jr, Chang, Steven L, Harshman, Lauren C, Presti, Joseph C Jr
Publikováno v:
Journal of Clinical Oncology; 9/1/2010, Vol. 28 Issue 25, p3951-3957, 7p
Autor:
Lauren C. Harshman, Nikhil Waingankar, Simon J. Crabb, Matthew D. Galsky, Andrea Necchi, Sumanta K. Pal, Thomas Powles, Rachel Jia, Ulka N. Vaishampayan, Elizabeth R. Plimack, N. Peter Wiklund, Bart S. Ferket, Alberto Martini, Jonathan E. Rosenberg, John P. Sfakianos, Madhu Mazumdar, Evan Y. Yu, Reza Mehrazin
Publikováno v:
Cancer. 125:3155-3163
BACKGROUND Achieving a pathologic complete response (pCR) with neoadjuvant chemotherapy (NAC) in patients with muscle-invasive bladder cancer (MIBC) has been associated with improved overall survival (OS). This study was aimed at evaluating the impac
Autor:
Vadim S. Koshkin, Joaquim Bellmunt, Matthew D. Galsky, Sylvain Ladoire, B.J. Eigl, Bas W.G. van Rhijn, Andrea Necchi, Johnathan E. Rosenberg, Guenter Niegisch, Kees Hendricksen, Salvatore Lo Vullo, Daniel W. Bowles, Sandy Srinivas, Aristotelis Bamias, Ali Reza Golshayan, Evan Y. Yu, Florian Roghmann, Michael Woods, Matthew I. Milowsky, Jakub Dobruch, Petros Grivas, Evanguelos Xylinas, Dominik D. Berthold, Yu-Ning Wong, Neeraj Agarwal, Srikala S. Sridhar, Jack Baniel, Lucia Nappi, Federica Recine, Ulka N. Vaishampayan, Lauren C. Harshman, Ugo De Giorgi, Simon J. Crabb, Luigi Mariani, Carsten Ohlmann, Ajjaj Alva, Sumanta K. Pal, Thomas Powles, Christine Theodore, Cora N. Sternberg
Background: Limited data is available on the role, and extent of, postchemotherapy lymphadenectomy (PC-LND) in patients with clinical evidence of pelvic (cN1-3) or retroperitoneal (RP) lymph node spread from urothelial bladder carcinoma. Objective: T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1307c446564231a2fa47c997161a8a88
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020075093&doi=10.1016/j.euf.2017.05.006&partnerID=40&md5=33648af8ff902fe82347274fdb063143
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020075093&doi=10.1016/j.euf.2017.05.006&partnerID=40&md5=33648af8ff902fe82347274fdb063143
Autor:
Sumanta K. Pal, Thomas Powles, Lauren C. Harshman, Ugo De Giorgi, Christine Theodore, Aristotelis Bamias, Simon J. Crabb, Elizabeth R. Plimack, Christina Bamia, Ulka N. Vaishampayan, Joaquim Bellmunt, Guenter Niegisch, Cora N. Sternberg, Andrea Necchi, Sandy Srinivas, Jonathan E. Rosenberg, Matthew D. Galsky, Michalis Liontos, Kimon Tzannis, Evan Y. Yu, Neeraj Agarwal, Sylvain Ladoire
Background The impact of cisplatin use on long-term survival of unselected patients with advanced urinary tract cancer (aUTC) has not been adequately investigated. We used a multinational database to study long-term survival and the impact of treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f66b065ad9bbf34c780430193e00d1
Autor:
Lauren C. Harshman, Ugo De Giorgi, Kevin Chan, Simon J. Crabb, Ulka N. Vaishampayan, Evan Y. Yu, Guru Sonpavde, Günter Niegisch, Cora N. Sternberg, Joaquim Bellmunt, Ali Reza Golshayan, Yu-Ning Wong, Sylvain Ladoire, Rafael Morales-Barrera, Syed A. Hussain, Ajjai Alva, Jonathan E. Rosenberg, Andrea Necchi, Simon Chowdhury, Matthew I. Milowsky, Gregory R. Pond, Daniel W. Bowles, Aristotelis Bamias, Jack Baniel, Matthew D. Galsky, Srikala S. Sridhar, Marc C. Smaldone, Sandy Srinivas, Dominik Berthold, Neeraj Agarwal, Sumanta K. Pal, Thomas Powles, Christine Theodore, Linda Cerbone, Rosalia Viterbo
Publikováno v:
European Urology Focus
European Urology Focus, Elsevier, 2018, 4 (6), pp.937-945. ⟨10.1016/j.euf.2017.03.011⟩
European Urology Focus, Elsevier, 2018, 4 (6), pp.937-945. ⟨10.1016/j.euf.2017.03.011⟩
Background: Little is known about the outcomes of robot-assisted radical cystectomy (RARC) compared to open radical cystectomy (ORC) combined with perioperative chemotherapy for muscle-invasive urothelial bladder cancer (UBC). Objective: To evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc30dcb8081be78c359d6685fc6fd8eb
https://hal.archives-ouvertes.fr/hal-01697161
https://hal.archives-ouvertes.fr/hal-01697161
Autor:
Aristotelis Bamias, Evan Y. Yu, Andrea Necchi, Joaquim Bellmunt, Gabriella Del Bene, Cora N. Sternberg, Diana Giannarelli, Sumanta K. Pal, Thomas Powles, Günter Niegisch, Elizabeth R. Plimack, Jack Baniel, Sylvain Ladoire, Ajjai Alva, Fabio Calabrò, Matthew D. Galsky, Neeraj Agarwal, Ulka N. Vaishampayan, Lauren C. Harshman, Ugo De Giorgi, Simon J. Crabb
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Frontiers, 2018, 8, pp.463. ⟨10.3389/fonc.2018.00463⟩
Frontiers in Oncology, Vol 8 (2018)
Frontiers in Oncology, Frontiers, 2018, 8, pp.463. ⟨10.3389/fonc.2018.00463⟩
Frontiers in Oncology, Vol 8 (2018)
Background: MIBC is an aggressive disease, with 5-year survival rates ranging from 36% to 48% for p T3/p T4/p N+tumors. Perioperative treatment can improve overall survival, with more robust evidence in favor of neoadjuvant chemotherapy. Few randomiz
Autor:
Ajjai Alva, Jonathan E. Rosenberg, Matthew D. Galsky, Andrea Necchi, U. De Giorgi, Thomas Powles, Joaquim Bellmunt, Michalis Liontos, L. Cerbone, Yu-Ning Wong, Aristotelis Bamias, Kimon Tzannis, Evan Y. Yu, Neeraj Agarwal, S. Kumar Pal, Lauren C. Harshman, Simon J. Crabb, Ulka N. Vaishampayan, Cora N. Sternberg, Günter Niegisch, Sylvain Ladoire, S. Srinivas
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2018, 29 (2), pp.361-369. ⟨10.1093/annonc/mdx692⟩
Ann Oncol
Annals of Oncology, Elsevier, 2018, 29 (2), pp.361-369. ⟨10.1093/annonc/mdx692⟩
Ann Oncol
BackgroundCisplatin-based combination chemotherapy is the standard treatment for advanced urinary tract cancer (aUTC) but 50% of patients are ineligible for cisplatin according to recently published criteria. We used a multinational database to study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b703ebda016172e649223f10d6c708d1
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01715016
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01715016
Autor:
Aristotelis Bamias, Günter Niegisch, Jonathan E. Rosenberg, Sylvain Ladoire, Dominik Berthold, Neeraj Agarwal, Joaquim Bellmunt, Daniel W. Bowles, Andrea Necchi, Sandy Srinivas, Lauren C. Harshman, Jack Baniel, Simon J. Crabb, Elizabeth R. Plimack, Gregory R. Pond, Evan Y. Yu, Matthew D. Galsky, Sumanta K. Pal, Thomas Powles
Publikováno v:
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Elsevier, 2017, 〈https://www.sciencedirect.com/science/article/pii/S155876731730318X?via%3Dihub〉. 〈10.1016/j.clgc.2017.10.012〉
Clinical Genitourinary Cancer, Elsevier, 2018, 16 (2), pp.e483-e490. ⟨10.1016/j.clgc.2017.10.012⟩
Clin Genitourin Cancer
Clinical Genitourinary Cancer, Elsevier, 2017, 〈https://www.sciencedirect.com/science/article/pii/S155876731730318X?via%3Dihub〉. 〈10.1016/j.clgc.2017.10.012〉
Clinical Genitourinary Cancer, Elsevier, 2018, 16 (2), pp.e483-e490. ⟨10.1016/j.clgc.2017.10.012⟩
Clin Genitourin Cancer
Worldwide, patients with urothelial carcinoma characterized by a bone-exclusive metastatic spread usually present with poor performance status, have limited access to active therapy, and have a poor outcome. Consequently, treatments offered and outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::992ef0806144a1e1198da3fd32167a89
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01707025
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01707025
Autor:
Yu-Ning Wong, Risc Investigators, Aristotelis Bamias, Ajjai Alva, Jonathan E. Rosenberg, Sylvain Ladoire, Lauren C. Harshman, Ugo De Giorgi, Martin F. Casey, Evan Y. Yu, Sumanta K. Pal, Matthew D. Galsky, Thomas Powles, Joaquim Bellmunt, Neeraj Agarwal, Guenter Niegisch, Simon J. Crabb, Andrea Necchi, Federica Recine, Ulka N. Vaishampayan, Jorge Ramos
Publikováno v:
Cancer Medicine
Cancer Medicine, Wiley, 2017, 6 (1), pp.186-194. ⟨10.1002/cam4.986⟩
Cancer Medicine, Wiley, 2017, 6 (1), pp.186-194. ⟨10.1002/cam4.986⟩
Venous thromboembolism (VTE) is common in cancer patients. However, little is known about VTE risk in metastatic urothelial carcinoma or variant histologies (UC/VH). We sought to characterize the incidence, associative factors, including whether vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf51bf0d21f5038a67532befa6faf2d
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01556032
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01556032